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Inhibition of acid secretion by the nonsteroidal anti-inflammatory
drugs diclofenac and piroxicam in isolated gastric glands: analysis of
a multifocal mechanism. Am J Physiol Gastrointest Liver Physiol 286:
G711–G721, 2004. First published December 23, 2003; 10.1152/
ajpgi.00305.2003.—In nonstimulated rabbit gastric glands, acetylsal-
icylic acid (10–500 M) and indomethacin (3–300 M) did not
significantly modify the basal rate of acid secretion, whereas diclofe-
nac and piroxicam (10–1,000 M each) caused a marked and dose-
dependent inhibitory effect (EC50  138 and 280 M, respectively).
In gastric glands stimulated by histamine (100 M), diclofenac also
reduced the rate of acid formation in a dose-dependent manner. In
contrast, acetylsalicylic acid, indomethacin, and piroxicam exerted a
biphasic effect; thus low concentrations (3–100 M) of these three
agents significantly increased the rate of histamine-stimulated acid
secretion (10–20% over the corresponding control value) by a cAMP-
independent mechanism, whereas higher concentrations reduced the
rate of acid formation. With respect to underlying biochemical mech-
anisms that could mediate inhibitory effects of NSAIDs on gastric
acid formation, it was observed that both diclofenac and piroxicam,
but not acetylsalicylic acid or indomethacin, decreased the glandular
content of ATP, inhibited hydrolytic activity of gastric gland micro-
somal H-K-ATPase, and reduced the rate of H-K-ATPase-
dependent proton transport across microsomal membranes in a dose-
dependent manner. Furthermore, diclofenac and piroxicam also sig-
nificantly increased passive permeability of microsomal membranes
to protons. In conclusion, our work shows that diclofenac and piroxi-
cam cause a significant reduction in the rate of basal and histamine-
stimulated acid formation in isolated rabbit gastric glands at concen-
trations that can be attained in the gastric lumen of patients treated
with these drugs. Mechanisms involved in these inhibitory effects
appear to be multifocal and include different steps of stimulus-
secretion coupling.
rabbit gastric glands; H-K-ATPase; proton transport; proton per-
meability
THERAPEUTIC USE OF NONSTEROIDAL anti-inflammatory drugs
(NSAIDs) is frequently associated with gastrointestinal alter-
ations, which include gastric erosion, peptic ulcer formation
and perforation, major upper gastrointestinal hemorrhage and
inflammation, and change in the permeability of the intestine
and lower bowel (5, 55). All of these effects have long been
associated with the inhibition of cyclooxygenase activity with
the subsequent blockade of prostaglandin biosynthesis in the
gastrointestinal mucosa (39, 49, 53, 55). However, the molec-
ular basis of NSAID toxicity appears to be more complex, and
the exact pathogenic mechanism remains to be elucidated.
Moreover, the mechanisms responsible for the gastrointestinal
damage may differ from one region of the digestive system to
another (16, 49, 55).
Gastric damage provoked by NSAIDs seems to be due not
only to their ability to suppress prostaglandin biosynthesis but
also to topical irritant effects of NSAIDs on the gastric epithe-
lium. These topical irritant effects are predominantly observed
with acidic NSAIDs, which can be accumulated inside gastric
cells because of the phenomenon of ion trapping (5, 47, 55).
However, other side effects of NSAIDs, like disruption of the
mucosal barrier (16, 47), uncoupling of oxidative phosphory-
lation (32, 49), neutrophil-dependent microvascular injuries
(55, 56), and oxygen radical-mediated lipid peroxidation (38,
55), may also be important primary events that lead to gastric
mucosal injury.
In connection with the phenomenon of ion trapping (5, 47,
55), gastric acid has been shown to play an important permis-
sive role in NSAID-associated mucosal injury (46). Most
NSAIDs are weak acids that selectively concentrate inside
gastric cells at low intragastric pH (5, 47). The intracellular
accumulation of NSAIDs alters ionic fluxes across the gastric
mucosa, with sodium and potassium ions being released into
the luminal fluid, whereas hydrogen ions diffuse back from the
lumen to the mucosa, potentiating the gastric damage (49, 55).
Because of these effects, the influence of NSAIDs on the
rate of gastric acid secretion has been a relevant matter of
interest for many authors. Different in vivo studies carried out
in humans have demonstrated that both acetylsalicylic acid and
indomethacin are able to increase the basal rate of acid forma-
tion (8, 12, 21, 29) and to potentiate acid secretion stimulated
by histamine (21, 29). Furthermore, in vitro studies carried out
in isolated rabbit fundic glands (48), in preparations of rat
gastric mucosa (41), or in isolated rabbit parietal cells (27, 28,
37) have demonstrated that micromolar concentrations of as-
pirin and other NSAIDs, like indomethacin, piroxicam, and
naproxen, may potentiate gastric acid secretion stimulated by
histamine, dibutyryl cAMP, or forskolin without affecting the
basal rate of acid formation. The biochemical mechanism of
this potentiation is not well established. However, it appears to
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be dependent on the presence of Ca2 in the incubation
medium and occurs without significant changes in either cAMP
or inositol 1,4,5-trisphosphate levels or in H-K-ATPase
activity (27, 48).
The present study was undertaken to investigate the influ-
ence of different NSAIDs, like acetylsalicylic acid, indometh-
acin, diclofenac, and piroxicam, on the rate of acid formation,
in isolated rabbit gastric glands incubated either under basal
conditions or in the presence of histamine (100 M). The
assayed NSAIDs were used in a wide range of concentrations,
including those calculated to be present in the gastric lumen of
patients treated with these drugs. We also tried to correlate the
resulting changes in gastric acid secretion elicited by the
NSAIDs with modifications in the glandular content of ATP
and cAMP, as well as with the effect of these agents on the
H-K-ATPase activity and on the rate of passive permeabil-
ity of microsomal membranes to protons.
Our findings show that at the concentrations used, both
piroxicam and diclofenac, but not acetylsalicylic acid or indo-
methacin, exert a marked and dose-dependent inhibition of the
basal and histamine-stimulated rates of acid formation in iso-
lated rabbit gastric glands. The inhibitory effects elicited by
both piroxicam and diclofenac occur in parallel with a dimi-
nution in the glandular content of ATP. Furthermore, concen-
trations of these two agents able to block acid formation in
isolated gastric glands cause a significant inhibition of the
hydrolytic activity of H-K-ATPase, a reduction in the H-
K-ATPase-dependent proton transport across microsomal
membranes, and an increase in the passive permeability of
these membranes to protons. On the other hand, low concen-
trations (3–100 M) of acetylsalicylic acid, indomethacin, and
piroxicam cause a small increase in the rate of histamine-
stimulated acid formation, apparently through a cAMP-inde-
pendent mechanism.
MATERIALS AND METHODS
Animals. Male rabbits (New Zealand White, 1.5–2.5 kg body wt)
from our inbred colony were used. The animals were fed on a standard
chow (N-25; Morago´n, Toledo, Spain), were given water ad libitum,
and were housed in animal quarters at a constant temperature of 23°C
with a fixed 12:12-h light-dark cycle. The animal experimentation
described was approved by the Ethics in Human and Animal Exper-
imentation Committee of the Universidad Auto´noma de Madrid. All
animals were anaesthetized with pentobarbital sodium (30 mg/kg
body wt iv) immediately before the experiment.
Reagents. Collagenase A from Clostridium histolyticum (type I),
histamine dihydrochloride, acetylsalicylic acid, piroxicam, diclofenac,
indomethacin, nigericin, IBMX, N,N-dicyclohexylcarbodiimide
(DCCD), valinomycin, and acridine orange were obtained from Sigma
(St. Louis, MO). [Dimethylamine-14C]aminopyrine (100–120 mCi/
mmol) and the cAMP 125I-labeled radioimmunoassay kit were pur-
chased from Amersham Pharmacia Biotech (Piscataway, NJ). The
remaining reagents, all of analytical grade, were from Roche Molec-
ular Biochemicals (Mannheim, Germany), Sigma, or Merck (Darm-
stadt, Germany).
Gastric gland isolation. Gastric glands were prepared basically
according to the method reported by Berglindh and O¨ brink (2), as
described by Rossi et al. (44). Briefly, the stomach of an anaesthetized
rabbit was perfused in situ with phosphate-buffered saline (in mM:
149.6 NaCl, 3 K2HPO4, and 0.64 NaH2PO4, pH 7.4) at 37°C. The
mucosa from the gastric corpus was freed from the muscle layers,
minced, and incubated with collagenase (0.5 mg/ml) at 37°C for
30–45 min. The resulting digest was filtered through a nylon mesh,
rinsed three times, and resuspended at a final concentration of 2–5 mg
dry weight/ml in medium A (in mM: 132.4 NaCl, 5.4 KCl, 5
Na2HPO4, 1 NaH2PO4, 1.2 MgSO4, 1 CaCl2, 0.5 dithiothreitol, 15
HEPES, and 10 glucose, with 10 mg/l phenol red and 1 mg/ml bovine
serum albumin at pH 7.3). The incubations were performed with
agitation (100 strokes/min) at 37°C in an 95% O2-5% CO2 atmo-
sphere. NSAIDs were dissolved in 5 mM NaOH. Control incubations
of gastric glands were carried out in the presence of NaOH at the same
final concentrations. No significant differences were observed be-
tween control and saline (0.9% NaCl) incubations with respect to any
assayed metabolic parameter.
Isolated rabbit gastric glands had the typical rodlike appearance
(0.3–0.7 mm in length). More than 95% of the different cells present
in the glands excluded the trypan blue dye (0.1% wt/vol). The dry
weight of the gastric gland suspensions was calculated in 1-ml
aliquots; after centrifugation (10,000 g for 3 min), the pellets were
dried overnight at 60°C and then weighed.
Measurement of acid production. Acid secretion by isolated gastric
glands was determined by accumulation of [dimethylamine-14C]amino-
pyrine in the canalicular compartment, following the method de-
scribed by Berglindh et al. (1), with the modifications made by Del
Valle et al. (6).
Preparation of gastric gland microsomes. Nonstimulated rabbit
gastric glands were homogenized with 20 strokes of a motor-driven
(2,500 rpm) Teflon pestle in a Potter homogenizer in a medium
containing 0.25 M sucrose and 10 mM TrisHCl (pH 7.4). The
homogenate was centrifuged at 15,000 g for 15 min. The resulting
supernatant was then collected and centrifuged again at 105,000 g for
60 min. The microsomal pellet obtained was resuspended in the
homogenization medium and kept in liquid nitrogen until use. All of
these procedures were carried out at 0–4°C.
ATP and cAMP assays. The glandular content of ATP was deter-
mined fluorometrically according to the method described by Lowry
and Passonneau (31). Briefly, after appropriate incubations in the
presence of different concentrations of NSAIDs for 30 min at 37°C,
aliquots of the gland suspension were treated with 5% HClO4 and
centrifuged. The supernatants were neutralized with imidazole/K2CO3
(0.3 M/3 M) and centrifuged again. ATP was measured in these
neutralized extracts.
Glandular content of cAMP was determined by using a radioim-
munologic method as previously described (7). Gastric glands were
incubated at 37°C for 15 min with different concentrations of NSAIDs
in the absence or presence of histamine (100 M). After deproteina-
tion with 5% trichloroacetic acid and subsequent centrifugation (3,000
g for 15 min), cAMP was determined in the resulting supernatants.
Enzyme assays. Glandular lactate dehydrogenase (EC 1.1.1.27) and
phosphoglucose isomerase (EC 5.3.1.9) activities were measured by
standard spectrophotometric methods (51, 54). H-K-ATPase (EC
3.6.1.3) activity was assayed in gastric gland microsomes, basically
according to the method reported by Hersey et al. (20). For the
enzyme assay, gastric gland microsomes (0.1 mg of protein), previ-
ously incubated with or without different concentrations of NSAIDs
for 10 min (vol/vol) at 37°C, were added to an assay mixture
containing (in mM) 150 KCl, 10 PIPES, 1 MgSO4, 5 Mg ATP, 1
EGTA, and 0.1 ouabain, at pH 7.2, and 10 g/ml valinomycin, 10 M
DCCD, 2.5 g/ml oligomycin, and the indicated NSAID concentra-
tions. The reaction was carried out at 37°C for 20 min and was
stopped by adding one volume of 10% ice-cold trichloroacetic acid.
After centrifugation (10,000 g for 2 min), inorganic phosphate was
measured in the resulting supernatant (14). Nonspecific ATPase ac-
tivity (measured under similar conditions but in the absence of
valinomycin and substituting 150 mM KCl with 250 mM sucrose in
the reaction mixture) was subtracted from the estimated H-K-
ATPase activity.
Proton transport assays. H-K-ATPase-dependent transport of
protons across microsomal membranes was assayed by using the
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fluorescent amine acridine orange method (24, 25) as described by
Del Valle et al. (7). The assay was performed at room temperature
(21–23 °C) in a Perkin-Elmer LS-5B spectrofluorometer. Microsomes
(80 g of protein/ml) were suspended in a medium containing (in
mM) 10 PIPES, 150 KCl, 1 MgCl2, 0.1 EDTA, 1 ATP, and 10 M
valinomycin, at pH 7.2, in the absence or in the presence of different
concentrations of NSAIDs. Excitation and emission wavelengths used
were 493 and 530 nm, respectively.
The influence of diclofenac and piroxicam on passive H perme-
ability of microsomal membranes was studied, as previously de-
scribed (7). For this purpose, an ATP-dependent proton gradient
across the microsomal membranes was generated first by the addition
of 10 M valinomycin. Then, the H-K-ATPase activity was
blocked by the rapid hydrolysis of ATP. This was achieved by the
incorporation of glucose (5 mM) and hexokinase (18 U) to the
reaction mixture immediately before the addition of either saline or
NSAIDs (42).
Statistical analysis. Statistical significance of differences was cal-
culated by the paired Student’s t-test. Differences were considered
statistically significant when the P value was 0.05. The calculated
concentrations of NSAIDs corresponding to the half-maximal effects
(EC50) were calculated by the computer program Fig.P (Fig.P Soft-
ware, Durham, NC).
RESULTS
Effects of NSAIDs on the cellular integrity of the isolated
gastric glands. In the first part of the study, we examined the
influence of different concentrations of NSAIDs on the integ-
rity of the cells present in the isolated rabbit gastric glands. For
this purpose, the percentage of cells stained with trypan blue
(0.1%) as well as the amounts of both lactate dehydrogenase
and phosphoglucose isomerase released into the incubation
medium were estimated in gastric gland suspensions treated for
30 min with different concentrations of NSAIDs. The amount
of cells excluding the trypan blue stain in gastric glands
incubated in the absence of NSAIDs was 98  0.5%, and this
value was not significantly modified by the presence of either
acetylsalicylic acid, diclofenac, piroxicam (10–1,000 M
each), or indomethacin (3–300 M) in the incubation medium
(data not shown). With respect to the influence of NSAIDs on
the release of cytosolic enzymes from the glandular cells, it
was observed that, among the assayed NSAIDs, only diclofe-
nac at a concentration of 1 mM significantly accelerated the
release of both lactate dehydrogenase and phosphoglucose
isomerase into the incubation medium (lactate dehydrogenase
release: 5.69  0.4 and 9.72  0.8 for saline and 1 mM
diclofenac incubations, respectively; phosphoglucose isomer-
ase release: 5.56  0.4 and 11.71  0.4 for saline and 1 mM
diclofenac incubations. Values are expressed as percentages of
total enzyme activities present in the gastric gland incubations;
n  3 experiments).
Influence of NSAIDs on gastric acid secretion. Addition of
acetylsalicylic acid (10–1,000 M) or indomethacin (3–300
M) to the incubation medium did not significantly modify the
basal rate of acid formation (Fig. 1). In contrast, diclofenac and
piroxicam (10–1,000 M each) significantly reduced the basal
rate of acid secretion in a dose-dependent manner; in both
cases, the maximal effects (96 and 74% inhibition for diclofe-
nac and piroxicam, respectively) were observed at concentra-
tions of 1 mM, with 138 and 280 M being the calculated EC50
values, respectively. Treatment of isolated gastric glands with
histamine (100 M) increased the rate of acid formation
approximately fourfold (Fig. 1). In the presence of this secre-
tagogue, low concentrations (3–100 M) of either acetylsali-
cylic acid or indomethacin enhanced the rate of acid secretion
(10–20% over the control value), an effect that disappeared at
higher NSAID concentrations. In contrast, diclofenac caused a
marked dose-dependent reduction in the rate of acid formation
Fig. 1. Influence of different NSAIDs on the
rate of acid formation in isolated rabbit gas-
tric glands. Isolated rabbit gastric glands
were incubated at 37°C for 30 min in the
absence or presence of different concentra-
tions of NSAIDs under basal conditions
(open symbols) or with 100 M histamine
(closed symbols) as indicated in MATERIALS
AND METHODS. Values represent means SE
of 3–4 separate experiments carried out in
duplicate. *P  0.05, **P  0.01, and
***P  0.005 vs. the corresponding control
basal value; P  0.05 and P  0.01
vs. the corresponding control histamine
value.
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in histamine-treated gastric glands; the maximal inhibitory
effect (98%) was observed at 1 mM diclofenac, and the
calculated EC50 value was 100 M. However, under these
conditions, piroxicam exerted a biphasic effect on the rate of
acid formation; thus low concentrations (3–100 M) of this
NSAID caused a small but statistically significant increase
(10–20% over the corresponding control value) in the rate of
histamine-stimulated acid formation, but higher concentrations
showed a clear inhibitory effect. In fact, piroxicam at the
highest concentrations tested (1 mM) blocked acid secretion
almost completely (that fell below the basal rate); the calcu-
lated EC50 value for piroxicam as inhibitor of histamine-
stimulated gastric acid secretion was 210 M.
With respect to the reinforcement of histamine-stimulated
acid secretion by low micromolar concentrations of acetylsal-
icylic acid, indomethacin, and piroxicam, our data show a
small but statistically significant effect (10–20% over the
corresponding histamine value). These results contrast with
those previously reported by Murthy and Levine (37) and
Levine et al. (27), showing that acetylsalicylic acid (10 M)
and indomethacin (1–100 M) reinforced the rate of acid
formation in isolated parietal cells treated with 100 M hista-
mine by 50–100%. On the other hand, Schwartzel et al. (48)
observed that, in isolated rabbit gastric glands, indomethacin
(100 M) increased the rate of aminopyrine uptake stimulated
by histamine (1–100 M) by approximately threefold. We
have no clear explanation for the less-marked NSAID rein-
forcement of histamine-mediated acid secretion observed by
us. The possibility that the concentration of histamine used
(100 M) could maximally stimulate the rate of acid formation
in our gastric gland preparations, minimizing in this way the
potentiation elicited by low concentrations of NSAIDs, should
not be overlooked.
Effect of NSAIDs on ATP and cAMP levels in isolated
gastric glands. It is well established that gastric acid formation
is an ATP-dependent process. To investigate whether or not the
inhibition of the rate of acid formation elicited by diclofenac
and piroxicam could be due to a reduction in the glandular
content of ATP, we measured the levels of this adenine
nucleotide in gastric glands incubated for 30 min with different
concentrations of the indicated NSAIDs. As shown in Fig. 2,
neither acetylsalicylic acid nor indomethacin, which did not
inhibit the basal rate of acid formation at the concentrations
used, significantly modified the glandular content of ATP. In
contrast, diclofenac and piroxicam caused a marked reduction
in the ATP levels in a dose-dependent manner. The maximal
effect (a reduction of 85%) was observed in the presence of
1 mM of either diclofenac or piroxicam; the calculated EC50
values were 254 and 361 M, respectively. As shown in Fig.
3, a statistically significant direct correlation could be estab-
lished between the basal rate of acid formation and the glan-
dular content of ATP in nonstimulated gastric glands incubated
with different concentrations of diclofenac and piroxicam. In
the case of diclofenac, this close correlation was most clearly
observed at the highest concentrations of NSAID used (0.25–1
mM). In fact, low concentrations of diclofenac (10100 M)
reduced the basal rate of acid formation without significant
changes in the glandular ATP content (Fig. 3A).
When the influence of the different NSAIDs on the glandular
content of cAMP was investigated (Table 1), it was observed
that none of these agents at the assayed concentrations signif-
icantly modified cAMP levels measured in gastric glands
incubated either in the absence of secretagogues or in the
presence of both histamine (100 M) and IBMX (0.5 mM). In
gastric glands incubated under the latter conditions, only pi-
Fig. 2. Effect of different NSAIDs on the ATP
content of isolated rabbit gastric glands. Isolated
rabbit gastric glands were incubated at 37°C for 30
min in the absence or presence of different concen-
trations of NSAIDs. Samples of the gastric gland
suspensions were then taken and processed as indi-
cated in MATERIALS AND METHODS. Values represent
means SE of 3 separate experiments carried out in
duplicate. *P  0.05 vs. the corresponding control
value.
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roxicam at the highest concentrations used (200 and 500 M)
significantly reduced the glandular content of cAMP (Table 1).
Effect of NSAIDs on H-K-ATPase activity. To gain more
insight into the mechanism by which diclofenac and piroxicam
inhibit gastric acid formation, we studied their effect on the
hydrolytic activity of H-K-ATPase assayed in microsomal
preparations obtained from nonstimulated gastric glands. As
shown in Table 2, both diclofenac and piroxicam were able to
cause a statistically significant inhibition of this enzyme activ-
ity in a dose-dependent manner. Maximal inhibitory effects
were observed at 1 mM NSAID concentration, diclofenac
being more effective than piroxicam (65 and 38% of inhibi-
tion, respectively). In contrast, acetylsalicylic acid and indo-
methacin, agents that did not show any inhibitory effect on
gastric acid secretion at the concentrations used, did not sig-
nificantly modify the hydrolytic activity of H-K-ATPase.
Effect of NSAIDs on H-K-ATPase-dependent proton
transport. We also investigated the influence of all the assayed
NSAIDs on the rate of H-K-ATPase-dependent proton
transport into microsomal vesicles, using the fluorometric
method previously described (7, 42). In this fluorometric assay
(Fig. 4, control incubation), addition of ATP to the reaction
mixture caused a small reduction of acridine orange fluores-
cence, possibly due to the presence of limited amounts of K
within the microsomal vesicles. The additional presence of the
K ionophore valinomycin increased the availability of K to
internal sites, maximally stimulating the H-K-ATPase ac-
tivity. Consequently, the ATP-induced intravesicular H accu-
mulation rose and the acridine fluorescence decreased to a
minimum value within a few minutes, remaining at this low
level for at least 15 minutes more (data not shown). The
subsequent addition of the K/H exchange ionophore nigeri-
cin (5 M) to the assay mixture rapidly dissipated the pH
gradient generated, and the acridine fluorescence returned to its
initial value in a few seconds. The initial rate of this valino-
mycin-induced decrease of fluorescence was considered an
index of the rate of the H-K-ATPase-dependent proton
transport into microsomal vesicles (7, 42). In good agreement
with the lack of inhibitory effects on gastric acid secretion and
on the hydrolytic activity of the H-K-ATPase, neither ace-
Fig. 3. Correlation between the basal rate of acid formation and the ATP
content of isolated rabbit gastric glands incubated with different concentrations
of diclofenac (A) and piroxicam (B). Data are from the experiments reported in
Figs. 1 and 2.
Table 1. Effect of different NSAIDs on cAMP levels in
isolated rabbit gastric glands
cAMP
Basal
Histamine (100 M)
 IBMX (500 M)
Saline 2.20  0.07 14.7  1.5
Acetylsalicyclic acid
10 M 2.41 0.03† 16.1  2.4†
500 M 2.03  0.15† 15.5  2.4†
Indomethacin
100 M 2.01  0.07† 15.1  2.3†
300 M 1.81  0.11† 12.4  2.6†
Diclofenac
100 M 2.06  0.31† 17.1  2.7†
500 M 1.99  0.08† 15.5  4.0†
Piroxicam
50 M 1.95 0.01† 14.7  2.7†
200 M 1.95  0.15† 11.3  2.0*
500 M 2.31  0.01† 9.6  2.1*
Values are means  SE of 3 different experiments and are given in
picomoles per milligram of dry weight. Isolated gastric glands were incubated
in the absence (basal) or presence of histamine plus IBMX for 15 min with
different concentrations of the indicated NSAIDs. *P  0.01; †no significant
difference vs. the corresponding saline value.
Table 2. Effect of different NSAIDs on H-K-ATPase
activity in isolated gastric gland microsomes
H-K-ATPase Activity
Saline 100.0  0.0
Acetylsalicylic acid
10 M 96.1 9.3§
500 M 95.6  3.9§
1 mM 94.8  2.1§
Indomethacin
50 M 94.6 5.2§
300 M 98.9  13.5§
Diclofenac
50 M 87.5 4.6§
250 M 74.9  2.9‡
500 M 62.8  1.9‡
1 mM 34.8  2.9†
Piroxicam
50 M 91.9 2.7§
200 M 86.1  2.8§
500 M 74.9  4.9*
1 mM 62.3  7.2*
Values are expressed as percentage vs. saline value (195.1  3.7 nmol
Pimin1mg protein1) and represent means  SE of 3 differents experi-
ments. H-K-ATPase activity was assayed by the hydrolysis of ATP in
microsomes obtained from nonstimulated rabbit gastric glands in the absence
or in the presence of different concentrations of NSAIDs, as indicated in
MATERIALS AND METHODS. * P 0.05; † P 0.01; ‡ P 0.005; §no significant
difference vs. the saline value.
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tylsalicylic acid nor indomethacin modified the rate of H-K-
ATPase-dependent proton transport at the assayed concentra-
tions (Fig. 4). In contrast, the presence of different concentra-
tions of either piroxicam or diclofenac in the assay mixture
caused a dose-dependent reduction in the rate of proton trans-
port mediated by the H-K-ATPase activity (Figs. 5 and 6).
The maximal inhibition elicited by piroxicam was 54% and
was observed at a concentration of 1 mM; the calculated EC50
value was 183 M (Fig. 5B). In contrast, 1 mM diclofenac
completely blocked the H-K-ATPase-dependent proton
transport, with 240 M being the calculated EC50 value
(Fig. 6B).
Effect of piroxicam and diclofenac on passive proton per-
meability. To study more specifically the influence of piroxi-
cam and diclofenac on passive H permeability of microsomal
membranes, we used the assay described by Reichstein et al.
(42), with the modifications made by Del Valle et al. (7). As
shown in the inset of Fig. 7A, first an ATP-dependent H
gradient across the microsomal membranes was generated by
addition of valinomycin. Afterward, H-K-ATPase activity
was blocked by the rapid hydrolysis of ATP through a glucose-
hexokinase trap. In a few seconds, a spontaneous recovery of
acridine orange fluorescence was observed, which corre-
sponded to the basal rate of passive H leakage from the
microsomal intravesicular space. In fact, when the maximal
fluorescence recovery was attained, addition of the K/H
exchange ionophore nigericin (5 M) to the assay mixture was
without effect (Fig. 7A, inset).
As shown in Fig. 7, when different concentrations (25–1,000
M) of piroxicam were incorporated into the assay mixture
immediately after the addition of the glucose-hexokinase trap,
a significant and dose-dependent increase in the rate of passive
H leakage from the microsomal intravesicular space was
observed. Taking the rate of microsomal H leakage measured
in the presence of 5 M nigericin (Fig. 7A) as 100%, the rate
of spontaneous or basal passive H permeability was 7.6 
1.2%. The presence of 1 mM piroxicam in the assay mixture
raised the rate of passive H permeability to 19.4  1.9%
(2.5-fold increase), 590 M being the calculated EC50 value.
Diclofenac (50–800 M) also caused a dose-dependent in-
crease in the rate of passive H leakage from microsomal
vesicles (Fig. 8). In this case, and in accord with its more
potent inhibitory effect on gastric acid secretion, 0.8 mM
diclofenac enhanced the rate of passive H leakage to 37 
2.5% (approximately fivefold increase), 290 M being the
calculated EC50 value for this NSAID. It is interesting to note
that in the case of diclofenac the calculated EC50 values for
both the inhibition of the H-K-ATPase-dependent proton
transport and the stimulation of the passive H permeability of
microsomal membranes were very similar (240 and 290 M,
respectively).
DISCUSSION
The therapeutic use of NSAIDs is frequently limited by
gastrointestinal side effects (3, 5, 55). These agents are thought
to cause injury in gastric mucosa by at least two main mech-
anisms. Thus by blocking prostaglandin biosynthesis, NSAIDs
impair different mucosal protective processes, like mucus and
bicarbonate secretion, blood flow, and epithelial cell turnover
and repair (53, 55). On the other hand, NSAIDs may also cause
Fig. 4. Effect of different concentrations of
acetylsalicylic acid (ASA) and indomethacin
(IND) on the rate of H-K-ATPase-depen-
dent proton transport in gastric gland micro-
somes. H-K-ATPase-dependent proton
transport was assayed in microsomes iso-
lated from nonstimulated rabbit gastric
glands by estimation of acridine orange flu-
orescence as indicated in MATERIALS AND
METHODS. The initial rate of 10 M valino-
mycin (VAL)-induced fluorescence decrease
was considered as the rate of H-K-
ATPase-dependent proton transport. Saline,
acetylsalicylic acid, or indomethacin was in-
corporated into the reaction mixture imme-
diately before the addition of ATP. Data are
from a single preparation of gastric gland
microsomes and are representative of at least
3 separate experiments. NIG, 5 M nigeri-
cin.
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topical irritant effects on gastric mucosa that are exacerbated
by acidity, because it promotes the absorption of NSAIDs in
their nonionized form (47, 55). Furthermore, when gastric
epithelial cells have been injured by either of these two
mechanisms, a second phase of damage mediated by luminal
gastric acid may aggravate the mucosal lesions (5, 55). In this
context, different in vivo animal studies have demonstrated
that NSAID-related gastric ulcers are markedly dependent on
luminal pH (9, 46, 47). Moreover, gastric acid suppression
Fig. 6. Effect of different concentrations of DCF on the rate of H-K-
ATPase-dependent proton transport in gastric gland microsomes. A: H-K-
ATPase-dependent proton transport was assayed in microsomes isolated from
nonstimulated rabbit gastric glands by estimation of acridine orange fluores-
cence as indicated in MATERIALS AND METHODS. The initial rate of 10 M
VAL-induced fluorescence decrease was considered as the rate of H-K-
ATPase-dependent proton transport. Saline or diclofenac (DCF) were incor-
porated into the reaction mixture immediately before the addition of ATP.
NIG, 5 M. Data are from a single preparation of gastric gland microsomes
and are representative of at least 3 separate experiments. B: dose-response
curve. Data are from 3–6 experiments similar to those reported in A and
represent the initial rates of VAL-induced fluorescence decrease measured in
the absence or presence of different concentrations of DCF. Values are
expressed as a percentage of the rate of VAL-induced fluorescence decrease
observed in the absence of DCF (100%).
Fig. 5. Effect of different concentrations of piroxicam (PIR) on the rate of
H-K-ATPase-dependent proton transport in gastric gland microsomes. A:
H-K-ATPase-dependent proton transport was assayed in microsomes iso-
lated from nonstimulated rabbit gastric glands by estimation of acridine orange
fluorescence as indicated in MATERIALS AND METHODS. The initial rate of 10 M
VAL-induced fluorescence decrease was considered as the rate of H-K-
ATPase-dependent proton transport. Saline or PIR was incorporated into the
reaction mixture immediately before the addition of ATP. NIG, 5 M. Data are
from a single preparation of gastric gland microsomes and are representative of
at least 3 separate experiments. B: dose-response curve. Data are from 3–6
experiments similar to those reported in A and represent the initial rates of
VAL-induced fluorescence decrease measured in the absence or presence of
different concentrations of PIR. Values are expressed as a percentage of the
rate of VAL-induced fluorescence decrease observed in the absence of PIR
(100%).
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therapies have been shown to prevent gastroduodenal ulcers
and erosions in patients taking NSAIDs daily (19, 50, 57).
The relevant role that acid secretion seems to play in the
NSAID-dependent gastric damage led us to carry out a systema-
tic study on the direct influence of different NSAIDs (acetyl-
salicylic acid, indomethacin, and diclofenac and piroxicam) on
basal and histamine-stimulated acid secretion, in isolated rabbit
gastric glands. The assayed NSAID concentrations ranged
from those at the low micromolar level (3–100 M) that could
be attained in plasma of patients treated with these drugs to
concentrations that could be reached in the gastric lumen after
oral NSAID administration (100–1,000 M). It must be said
that none of the assayed NSAIDs at the concentrations used
significantly modified the percentage of glandular cells that
excluded the trypan blue stain or the amount of lactate dehy-
drogenase and phosphoglucose isomerase released into the
incubation medium. Our results confirm previous findings (13,
23, 43) and indicate that the concentrations of NSAIDs used in
this study did not affect the cellular integrity of gastric glands.
Only diclofenac, at the highest concentration assayed (1 mM),
slightly increased the release of glandular lactate dehydroge-
nase and phosphoglucose isomerase into the medium (4–6%
of the total enzyme activities) compared with the release
observed in saline incubations.
When the influence of the selected NSAIDs on the basal rate
of acid formation was studied, two different patterns were
observed. On the one hand, acetylsalicylic acid (10–1,000 M)
and indomethacin (3–300 M) did not significantly modify the
rate of [14C]aminopyrine uptake in gastric glands incubated
under basal conditions. These results confirm previous reports
that showed that neither of these two NSAIDs affected the
basal rate of acid formation in in vitro studies carried out in
isolated rabbit fundic glands (48), in preparations of rat gastric
mucosa (41), or in isolated rabbit parietal cells (27, 28, 37).
Furthermore, these findings were highly consistent with the
Fig. 8. Effect different concentrations of DCF on the rate of passive proton
permeability in gastric gland microsomes. A: this study was carried out as
described for PIR in the legend of Fig. 7A. NIG, 5 M. Data are from a single
preparation of gastric gland microsomes and are representative of at least 4
separate experiments. B: dose-response curve. Data are from 4–6 experiments
similar to those reported in A. Values are expressed as the percentage of the
maximal rate of fluorescence recovery elicited by NIG (100%).
Fig. 7. Effect of different concentrations of PIR on the rate of passive proton
permeability in gastric gland microsomes. A: as shown in the inset, an
ATP-dependent proton gradient was first established in gastric gland micro-
somes. Then, a glucose/hexokinase trap (HK) was added to the assay mixture
to remove ATP and to block H-K-ATPase activity. Under these conditions,
the rate of fluorescence recovery is an index of passive leakage of protons from
the gastric gland microsomes. The ATP concentration was 1 mM. VAL, 10
M; NIG, 5 M. Data are from a single preparation of gastric gland
microsomes and are representative of at least 4 separate experiments. B:
dose-response curve. Data are from 4–6 experiments similar to those reported
in A. Values are expressed as the percentage of the maximal rate of fluores-
cence recovery elicited by NIG (100%).
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lack of statistically significant changes in the glandular content
of ATP, in the hydrolytic activity of microsomal H-K-
ATPase, and in the rate of the H-K-ATPase-dependent
proton transport across microsomal membranes observed in
response to all the assayed concentrations of either acetylsali-
cylic acid or indomethacin. Moreover, our data are in good
agreement with those previously reported by Levine et al. (27,
28) that showed that neither acetylsalicylic acid nor indometh-
acin significantly modified the hydrolytic activity of H-K-
ATPase assayed in rabbit gastric microsomes.
In contrast, both piroxicam and diclofenac (10–1,000 M
each) caused a significant and dose-dependent reduction in the
basal rate of acid formation. In both cases, the maximal
inhibitory effects (74 and 96% for piroxicam and diclofenac,
respectively) were observed at NSAID concentrations of 1
mM. For these two agents, the blockade in the basal rate of
gastric acid formation was significantly correlated with a re-
duction in the glandular content of ATP. Thus a close corre-
lation between these two parameters could be established for
piroxicam at all the NSAID concentrations used. However, in
the case of diclofenac, the correlation was only clearly ob-
served at the highest assayed concentrations (0.25–1 mM) and
not when this NSAID was used at much lower concentrations.
In fact, 10–100 M diclofenac was able to cause a significant
reduction in the basal rate of acid secretion without significant
changes in the glandular content of ATP. These findings
clearly indicate that diclofenac may inhibit gastric acid forma-
tion by ATP-dependent and ATP-independent mechanisms. In
connection with this, it must be mentioned that gastric acid
secretion is an energy-dependent process and a decrease in the
ATP content of parietal cells could be implicated in the
underlying mechanism by which piroxicam and diclofenac
inhibit gastric acid formation, mainly at the higher concentra-
tions of NSAIDs used. Supporting this hypothesis, it should be
noted that changes in the content of ATP observed in isolated
rabbit gastric glands closely reflect those occurring in cultured
gastric parietal cells (7). Furthermore, it has been demonstrated
that piroxicam and diclofenac, in the range of the assayed
concentrations, exert uncoupling effects on the oxidative phos-
phorylation in different types of cells, reducing their content of
ATP and blocking different cellular ATP-dependent processes
(4, 34, 36, 45). However, as shown in Table 3, the calculated
EC50 values for both piroxicam and diclofenac as inhibitors of
gastric acid secretion (280 and 138 M for basal acid forma-
tion, respectively) were clearly lower than those obtained for
these two NSAIDs as blockers of ATP formation (361 and 254
M, respectively). These findings reinforce the concept that
ATP-independent mechanisms could also be implicated in the
inhibition of gastric acid formation by diclofenac and less
evidently by piroxicam.
When the influence of these two NSAIDs on H-K-
ATPase activity was assayed in gastric gland microsomes, it
was observed that both piroxicam and diclofenac caused a
significant and dose-dependent inhibition of the hydrolytic
activity of this enzyme, as well as of the rate of H-K-
ATPase-mediated proton transport into microsomal vesicles.
For these two processes, diclofenac caused a greater inhibitory
effect than piroxicam at all the concentrations used. This was
in accordance with the higher efficacy showed by diclofenac in
reducing gastric acid secretion, compared with that displayed
by piroxicam. However, it appears that the inhibition of the
H-K-ATPase hydrolytic activity does not completely ex-
plain the blockade of gastric acid formation caused by these
two NSAIDs. In fact, it must be mentioned that the inhibitory
effects elicited by piroxicam and diclofenac at concentrations
of 1 mM each on the basal rate of gastric acid formation (74
and 96% inhibition, respectively) were clearly more intense
than those caused by identical concentrations of these two
NSAIDs on the microsomal H-K-ATPase hydrolytic activ-
ity (38 and 65% inhibition, respectively). Moreover, the cal-
culated EC50 values for piroxicam and diclofenac as inhibitors
of this enzyme activity (333 and 	405 M) were much
greater, mainly in the case of diclofenac, than those obtained
for these two NSAIDs as blockers of gastric acid formation
(Table 3).
In contrast, the inhibitory effect caused by piroxicam on the
H-K-ATPase-mediated proton transport across microsomal
membranes appeared to be closely related to the reduction in
gastric acid formation elicited by this NSAID. Supporting this
reasoning, it must be noted that the maximal inhibitory effects
elicited by piroxicam (1 mM) on these two processes were
quite similar (73 and 60% inhibition, respectively). Moreover,
the calculated EC50 value for piroxicam as inhibitor of the
microsomal H-K-ATPase-mediated proton transport was
183 M, a value close to, and even lower than, those obtained
for this NSAID reducing both basal and histamine-stimulated
acid formation in isolated gastric glands (280 and 210 M,
respectively) (Table 3). In the case of diclofenac, although this
agent at a concentration of 1 mM was able to completely
suppress both gastric acid formation and the H-K-ATPase-
mediated proton transport across the microsomal membranes,
the accordance between the calculated EC50 values for these
two processes was not so close. In fact, the corresponding EC50
value for the microsomal H-K-ATPase-mediated proton
transport (240 M) was approximately double those obtained
for basal and histamine-stimulated gastric acid formation (138
and 100 M, respectively) (Table 3).
In studies carried out in artificial lipid bilayers (15, 18), in
cell membranes (18, 30, 35), and in isolated mitochondria (10,
11, 34, 52), it was demonstrated that NSAIDs at concentrations
in the high micromolar range may impair membrane perme-
ability for ions and small molecules. In connection with this,
we hypothesized that a potential increase in passive H per-
meability of cell membranes elicited by NSAIDs would dissi-
pate the H gradient generated by the H-K-ATPase activity,
resulting in a blockade of gastric acid formation. To learn
whether or not changes in membrane permeability to protons
Table 3. Calculated EC50 values for piroxicam and
diclofenac on different assayed biochemical parameters
EC50
Piroxicam Diclofenac
Basal acid secretion 280 138
Histamine-stimulated acid secretion 210 100
Glandular ATP levels 361 254
H-K-ATPase hydrolytic activity 333 	405*
H-K-ATPase-dependent proton transport 183 240
Passive proton permeability 590 290
Values are given in micromoles. *An “apparent” EC50 value because the
maximal inhibition was not attained with the highest diclofenac concentra-
tion used.
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could be implicated in the inhibitory effects elicited by both
piroxicam and diclofenac on gastric acid secretion, we inves-
tigated the influence of these two agents on passive permeabil-
ity to protons in microsomal membranes isolated from non-
stimulated gastric glands. Our results clearly show that both
piroxicam and diclofenac cause a dose-dependent increase in
passive permeability of microsomal membranes to protons.
Again, diclofenac was more potent than piroxicam at all the
assayed concentrations; this is in good agreement with the
higher efficacy shown by diclofenac in reducing the rate of
both basal and histamine-stimulated acid formation in isolated
gastric glands, as well as in blocking the hydrolytic activity of
the H-K-ATPase and the H-K-ATPase-mediated proton
transport in gastric gland microsomal membranes. Further-
more, it is interesting to note that in the case of piroxicam, the
increase in passive H permeability is a much less sensitive
process (EC50, 590 M) than the inhibition of acid formation
in isolated gastric glands (see the corresponding EC50 values in
Table 3). This indicates that the impairment of membrane
permeability to protons and small molecules is not the main
mechanism by which piroxicam inhibits gastric acid formation.
Rather, in view of the EC50 values obtained for the different
metabolic parameters modulated by piroxicam (Table 3), it
appears that the inhibition of H-K-ATPase-dependent pro-
ton transport is the process most closely related to the reduction
of gastric acid formation by this NSAID. In contrast, diclofe-
nac shows very similar EC50 values for the increase in passive
H permeability of microsomal membranes (290 M), for the
inhibition of the H-K-ATPase-mediated proton transport
into microsomal vesicles (240 M), and for the reduction of
the glandular ATP content (254 M) (Table 3), suggesting that
these three processes are all closely related. In fact, the ability
of diclofenac and other NSAIDs to alter the permeability of
microsomal and mitochondrial membranes to ions has been
demonstrated (10, 11, 18, 34, 52). This impairment of mem-
brane permeability could be the mechanism by which diclofe-
nac dissipates the H gradient generated by the H-K-
ATPase activity as well as the mode by which it uncouples the
mitochondrial oxidative phosphorylation. The consequence of
these two effects would be a blockade of gastric acid forma-
tion. However, as mentioned above, unknown ATP-indepen-
dent mechanisms could be implicated in the reduction of
gastric acid formation by low micromolar concentrations of
diclofenac (10–100 M) and less evidently of piroxicam (10–
50 M). In this respect, the possible synergistic interaction
between the effects of these two NSAIDs on H-K-ATPase
hydrolytic activity, H-K-ATPase-dependent proton trans-
port, and passive membrane permeability to protons could
facilitate the inhibition of gastric acid formation at concentra-
tions of NSAIDs that do not significantly affect the total
glandular ATP content.
Finally, we must comment that in recent years diclofenac
and other NSAIDs have been demonstrated to cause apoptosis
in different types of cells as inducers of mitochondrial mem-
brane permeability transition (MPT) (17, 22, 33, 40). MPT is
a nonselective inner mitochondrial membrane permeabilization
that may precede necrotic and apoptotic cell death (26), play-
ing an important role in the pathogenesis of NSAID-induced
ulcerogenesis (40). With this in mind, the possible induction of
the apoptotic process during the 30-min treatment of isolated
gastric glands with piroxicam and diclofenac cannot be ruled
out. Under these conditions, NSAID inhibition of gastric acid
formation could be considered as an early sign of cell death.
However, the short-term inhibitory effects of both piroxicam
and diclofenac on the glandular content of ATP, the hydrolytic
activity of H-K-ATPase, and the H-K-ATPase-depen-
dent proton transport, as well as their effects increasing passive
membrane permeability to protons, clearly may explain the
short-term blockade of gastric acid formation elicited by pi-
roxicam and diclofenac.
In conclusion, our work supports the concept that both
piroxicam and diclofenac inhibit acid secretion in isolated
rabbit gastric glands by a multifocal mechanism, affecting
different cellular processes whose relative relevance in the
reduction of acid formation depends on their particular sensi-
tivity to these NSAIDs.
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